Results 101 to 110 of about 130,251 (209)

MEK inhibitor retinopathy

Annals of Oncology, 2017
openaire   +1 more source

MEK Inhibitor WX-554 [PDF]

, 2020
openaire   +1 more source

Cardiovascular Surveillance in BRAF/MEK Inhibitor Therapy: Early Lessons from Prospective Data. [PDF]

JACC CardioOncol
Shah V, Nahle T, Guha A.
europepmc   +1 more source

MEK Inhibitor PD-98059 [PDF]

, 2020
openaire   +1 more source

Cardiotoxicity of BRAF/MEK Inhibitors

JACC: CardioOncology, 2023
Claire Glen, Sarah Adam, Kirsty McDowell, Ashita Waterston, Yun Yi Tan, Mark C. Petrie, Caroline J. Coats, Ninian N. Lang   +7 more
openaire   +1 more source

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models. [PDF]

PLoS One
Tomita Y, Link G, Ge Y, Gold ERH, Racanelli A, Cardona HJ, Romero M, Gadd S, Watanabe J, Uchida E, Hashizume R, Takata N, Pinero G, Hambardzumyan D, Spasojevic I, Hu G, Hennika T, Brat DJ, Green AL, Becher OJ.   +19 more
europepmc   +1 more source

MEK Inhibitor TAK-733 [PDF]

, 2020
openaire   +1 more source

MEK inhibitor nears approval [PDF]

Nature Biotechnology, 2013
openaire   +1 more source

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor [PDF]

, 2017
et al,, Tan, Benjamin R
core   +2 more sources

Safety and Efficacy of MEK Inhibitor Treatment for Gastric Precancerous Lesions. [PDF]

Gastroenterology
Goldenring JR, Jang B, Gotoda T, Yamaguchi N, Choi E, Nomura S, Gastric Precancer Working Group.   +6 more
europepmc   +1 more source